The Characteristics of Antioxidant Activity after Liver Transplantation in Biliary Atresia Patients by Chih-Jen Chen et al.
Research Article
The Characteristics of Antioxidant Activity after Liver
Transplantation in Biliary Atresia Patients
Chih-Jen Chen,1 Kuo-Shu Tang,1 Ying-Hsien Huang,1 Chao-Long Chen,2
Li-Tung Huang,1 Jiin-Haur Chuang,2 and Mao-Meng Tiao1
1Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,
Kaohsiung 83301, Taiwan
2Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,
Kaohsiung 83301, Taiwan
Correspondence should be addressed to Mao-Meng Tiao; pc006581@yahoo.com.tw
Received 8 January 2015; Revised 29 April 2015; Accepted 30 April 2015
Academic Editor: Maria-Angeles Aller
Copyright © 2015 Chih-Jen Chen et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Purpose. Cholestatic liver injury is associated with a high production of free radicals. The pathogenesis of liver injury in biliary
atresia (BA) patients is largely undefined. The goal of the present study was to clarify the oxidative damage and the changes in
antioxidant enzyme activities that occur during the development of BA and after liver transplantation (LT).Methods. We enrolled
BA patients and control subjects and collected their clinical information.The activities of antioxidant enzymes in BA patients before
LT (BA group) and after LT (LT group) were analyzed. Results. The number of mitochondrial DNA copies had increased in the LT
group compared with the BA group. Similarly, the activity of glutathione peroxidase had increased in the LT group compared with
the BA group.The level of glutathione was higher in the LT group than in the BA group. Malondialdehyde levels were decreased in
the LT group comparedwith the BA group.Conclusions.These data indicate that LT is associated with increased antioxidant enzyme
activities and decreasedmalondialdehyde levels in BA patients.Themanipulation ofmitochondria-associated antioxidative activity
might be an important future management strategy for BA.
1. Introduction
Biliary atresia (BA) is an important clinical problem involving
impairments in bile flow that manifest as neonatal jaundice
and can lead to progressive fibrosis and end-stage liver cir-
rhosis [1, 2]. Oxidative stress and mitochondrial dysfunction
are involved in the pathogenesis of chronic liver cholestasis
[3]. Oxidative stress in cells or tissues is an abnormal phe-
nomenon that occurs when the production of oxygen radicals
exceeds that of the antioxidant capacity [4]. These excess free
radicals damage essential cellular macromolecules, leading
to abnormal gene expression and cell death [4]. Antioxidant
enzymes catalyze the decomposition of these free radicals.
The major antioxidant enzymes include glutathione perox-
idase (GPx) and catalase (CAT), which differ in structure,
tissue distribution, and cofactor requirements [5].
Disturbances in the antioxidant system could play a role
in the pathogenesis of chronic liver disease [6–8] and could
result in different types of liver diseases in infancy [9]. It
is reported that serum oxidative stress indexes were signifi-
cantly higher in the inherited metabolic diseases group than
in the biliary atresia group [10]. GPx is the most important




) in mammalian cells
[11]. CAT, which is located in peroxisomes of all aerobic










water and oxygen without the production of free radicals.
The copy numbers of mitochondrial DNA (mtDNA) in
cells may change during cell growth and differentiation [13].
mtDNA is highly susceptible to oxidative stress that leads to
mitochondrial dysfunction [3, 14]. Previous studies suggest
that an increase in the mtDNA copy number in cells is
the result of a feedback mechanism that compensates for
defective mitochondria that affect subsequent cell growth
and morphology [14, 15]. Extrahepatic cholestatic patients
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present a significant decrease in the number ofmtDNAcopies
compared with controls [3].
Our previous report demonstrated that the level of
oxidative stress is lower after the Kasai operation. In addition,
themtDNA copy number is found to be higher after the Kasai
operation [2]. To our knowledge, no study has evaluated
the benefit of liver transplantation (LT) in BA patients in
terms of oxidants/antioxidants. Our hypothesis is that if
antioxidant levels are increased after LT [2, 10, 16, 17], then
the administration of antioxidants is needed in those cases
who hesitate to receive LT or in cases where a liver graft is
not available from donors. Therefore, our aim was to study
the oxidative status in children with BA by examining the
malondialdehyde (MDA) and antioxidant enzyme levels as
well as mitochondrial copy numbers.
2. Materials and Methods
2.1. Subjects. Participants were enrolled from the clinic at
the Chang Gung Memorial Hospital, Department of Pedi-
atrics, and liver team at the Kaohsiung Medical Center.
In all patients, BA was diagnosed clinically with DISIDA
scan, pathologic examination, computerized tomography,
or magnetic resonance imaging findings before LT. The
indications for LT among BA patients included end-stage
liver disease, recurrent cholangitis, recurrent gastrointestinal
bleeding, andportal hypertension. Patientswho received only
cyclosporine after LT were included. Those who received
other immunosuppressants were excluded. Normal healthy
individuals who tested negative in the allergy screen test
were included as a control group. Another control group
consisted of patients with idiopathic acute hepatitis. The
liver tissues were randomly obtained during Kasai operation.
Tissue samples from hepatitis cases were randomly obtained
using a modified Minghini needle (sure cut), and biliary
atresia cases who received LT had tissue samples randomly
obtained at 6months after LT. Liver tissues of normal controls
were obtained from the LT donors.Theywere stored at−80∘C
till assay. The total bilirubin levels and alanine transaminase
(ALT) and aspartate transaminase (AST) activities were
determined by a standard autoanalyzer (model 7450; Hitachi,
Tokyo, Japan). The study was approved by the Ethics and
Clinical Research Committee of the Chang Gung Memorial
Hospital.
2.2. GPx Activity and Glutathione. GPx activity was mea-
sured using a commercially available kit (Ransel; Randox
Lab, Crumlin, UK) for erythrocytes and homogenized liver
tissue. Liver biopsy samples were washed in phosphate buffer
at pH 7.4. Then, the tissue was homogenized in 5mL/g
cold buffer, which consisted of 50mM Tris-HCl, pH 7.5,
5mM EDTA, and 1 nM dithiothreitol. The homogenate was
centrifuged at 10,000 g for 15 minutes at 4∘C.The supernatant
was removed for assay of GPx. In the presence of glutathione
reductase (GR) and NADPH, oxidized glutathione (GSSG)
was immediately converted to the reduced form (GSH) with
a concomitant oxidation of NADPH toNADP+.The decrease
in absorbance at 340 nm after 1 and 2min was measured.
The result obtained was expressed in units per liter (U/L) of
hemolysate and was multiplied by the appropriate dilution
factor to obtain the result in U/L.
2.3. Determination of CAT Activity. The plasma and liver
supernatant assays were conducted on a Bradford assay (Bio-
Rad, Richmond, CA, USA) automated chemistry analyzer.
The CAT activity assay kit (Cayman Chemical, Ann Arbor,
MI, USA; catalog number 707002) and samples (20 𝜇L) were
placed on the instrument and assayed according to the man-
ufacturer’s protocol. Liver biopsy was washed with phosphate
buffer, pH 7.4, to remove red blood cells. The tissue was then
blotted dry, weighted, and followed by homogenization in
1.5mL cold buffer (50mM potassium phosphate and 1mM
EDTA, pH 7) and centrifugation at 10,000 g for 15 minutes at
4∘C.The supernatant was used for the assay.TheCAT activity
level was quantified spectrophotometrically at 540 nm. The
results were expressed as nanomoles per minute per milliliter
of protein. Standards and blanks were assayed in duplicate
and treated as samples (i.e., not placed in the calibration
positions). The average of 2 measurements was used in
subsequent statistical analysis of the data.
2.4. Determination of Plasma MDA Content. MDA is an end
product of peroxidative decomposition of polyenoic fatty
acids in the lipid peroxidation process, and its accumulation
in tissues is indicative of the extent of lipid peroxidation.
Plasma MDA was measured using the thiobarbituric acid
reactive substances (TBARS) assay. The TBARS reagent
(1mL)was added to an aliquot containing 0.5mL plasma, and
the mixture was heated for 20min at 100∘C. The antioxidant,
butylated hydroxytoluene, was added before heating the sam-
ples. After cooling on ice, samples were centrifuged at 840 g
for 15 minutes, and the absorbance of the supernatant was
read at 532 nm (A532). Blanks for each sample were prepared
and assessed in the same way to correct for the contribution
of A532 to the sample. TBARS results were expressed as
MDA equivalents by using 1,1,3,3-tetraethoxypropane as the
standard.
2.5. Determination of mtDNA Copy Number. DNA sam-
ples were extracted from peripheral blood leukocytes. The
mtDNA copy numbers were measured by real-time poly-
merase chain reaction (PCR) after correcting nuclear DNA
levels. The forward and reverse primers complementary
to nuclear 𝛽-actin gene were 5󸀠-GAAATCGTGCGTGAC-
ATTAAAG-3󸀠 and 5󸀠-ATCGGAACCGCTCATTG-3󸀠. The
forward and reverse primers for mtDNA, which were com-
plementary to the sequence of the mitochondrial ND1
gene, were 5󸀠-ATTCTAGCCACATCAAGTCTTT-3󸀠 and
5󸀠-GGAGGACGGATAAGAGGATAAT-3󸀠. PCR was per-
formed in a LightCycler 480 Real-Time PCR System (Roche
Co., Mannheim, Germany), using LightCycler 480 SYBR
Green I Master (Roche Co., Germany). DNA (10 ng) was
mixed with 10 𝜇L SYBR Green PCR Master Mix containing
10 nmol of forward and reverse primers, in a final volume of
20𝜇L.ThePCR conditionswere as follows: initial 50∘C2min,
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Table 1: Descriptive data of the children.
Groups Normal BA LT Hepatitis
(𝑛 = 26) (𝑛 = 26) (𝑛 = 26) (𝑛 = 6)
Age (yr) (mean ± standard error [SE]) 2.1 ± 1.5 1.9 ± 0.8 8.6 ± 0.9 2.4 ± 1.2
Sex (male/female) 1.1 : 1 1.1 : 1 0.8 : 1 0.8 : 1
Physical signs, number (%)
Jaundice 0 (0) 26 (100) 0 (0) 6 (100)
Edema of the lower limbs 0 (0) 0 (0) 0 (0) 0 (0)
Hepatomegaly 0 (0) 8 (30.7) 3 (11.5) 2 (33.3)
Splenomegaly 0 (0) 11 (42.3) 3 (11.5) 1 (16.7)
Ascites 0 (0) 2 (7.6) 0 (0) 0 (0)
Liver function tests (mean ± SE)
bil(D) (mg/dL) 0.2 ± 0.1∗∗ 4.4 ± 0.8∗ 0.3 ± 0.1∗∗ 3.4 ± 0.9∗
bil(T) (mg/dL) 0.50 ± 0.2∗∗ 6.5 ± 1.2∗ 0.8 ± 0.1∗∗ 5.1 ± 1.3∗
AST (U/L) 35.8 ± 3.8∗∗ 163.4 ± 30.5∗ 32.7 ± 5.7∗∗ 341.9 ± 177.3∗
ALT (U/L) 21.4 ± 5.6∗∗ 121.8 ± 26.4∗ 36.5 ± 6.4∗∗ 184.0 ± 110.9∗
ALP (U/L) 150.3 ± 15.4∗∗ 510.0 ± 81.3∗ 288.5 ± 25.8∗∗ 314.0 ± 152.0∗
Albumin (g [%]) 4.1 ± 0.2 3.0 ± 0.6 4.0 ± 0.4 3.1 ± 0.8
BA: biliary atresia before liver transplantation; LT: biliary atresia after liver transplantation; bil(D): direct bilirubin; bil(T): total bilirubin; AST: aspartate
aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase. All results represent means ± standard error (SE). ∗𝑃 < 0.05 versus normal;
∗∗
𝑃 < 0.05 versus BA.
95∘C 1min, 40 cycles of denaturation at 95∘C for 15 s, anneal-
ing at 60∘C for 20 s, and primer extension at 72∘C for 15 s, final
25∘C. The threshold cycle number (Ct) values of the 𝛽-actin
gene and the mitochondrial ND1 gene were determined for
each individual quantitative PCR run. Ct values were used as
a measure of the input copy number, and Ct value differences
were used to quantify mtDNA copy number relative to the 𝛽-
actin gene according to the following equation: relative copy
number (Rc) = 2ΔCt, where ΔCt is Ct
𝛽-𝑎𝑐𝑡𝑖𝑛− CtmtDNA [18].
Each measurement was performed at least 3 times and was
normalized in each experiment against a serial dilution of a
control DNA sample.
2.6. Statistical Analysis. SPSS forWindows version 13.0 (SPSS
Inc., Chicago, IL, USA) was used for statistical analysis.
Continuous variables were analyzed by independent t-test or
ANOVA. The correlation of total bilirubin levels and oxida-
tive stress and antioxidant enzyme activity was performed
using Spearman’s correlation analysis. Data are presented
as means ± SE. 𝑃 < 0.05 was considered statistically
significant. The sample size was calculated with PASS sample
size software, the two-sided confidence level >0.95, 𝑃 < 0.05,
and power value >0.8 with 𝛼 level <0.05.
3. Results
3.1. Patients’ Clinical Data. This study included 26 normal
healthy controls, 26 post-Kasai operation BA patients before
and after LT, and 6 acute hepatitis patients. The descriptive
data of the children included in this study are shown in
Table 1. The liver function and levels of AST, ALT, and
bilirubin were increased in the BA and acute hepatitis groups



































Figure 1: The activity of the antioxidant glutathione peroxidase
in plasma was significantly decreased in the biliary atresia group
(BA) before liver transplantation (LT) compared with the normal
control group and significantly increased after undergoing liver
transplantation in the LT group comparedwith the BAgroup, almost
reaching the level of the normal control group. Data represent the
mean ± SE. ∗
𝑃
< 0.05 versus BA.
decreased in the LT group compared with the BA group
(Table 1).
3.2. Oxidative Stress and Antioxidant Enzyme Activity. The
activity of the antioxidant GPx significantly increased in the
LT group compared with the BA group, almost reaching
the level in the normal control group and significantly
decreased in the BA group compared with the normal
controls (Figure 1).
The expression of glutathione (GSH) is significantly
increased in the LT group compared with the BA group,
almost reaching the level in the normal control group and
significantly decreased in the BA group compared with the
normal control group (Figure 2(a)). The GSH/glutathione











































Figure 2:The expression of (a) total glutathione (GSH) and (b) the GSH/glutathione disulfide (GSSG) ratio in plasma significantly decreased
in the biliary atresia group (BA) before liver transplantation (LT) compared with the normal control group and significantly increased after
undergoing liver transplantation in the LT group compared with the BA group, almost to the level of the normal control group. Data represent
the mean ± SE. ∗
𝑃




























Figure 3: The expression of catalase in plasma is significantly
decreased in the biliary atresia (BA) group before liver transplan-
tation (LT) compared with the normal control group and increased




disulfide ratio significantly increased in the LT group com-
pared with the BA group (Figure 2(b)).
The expression of CAT significantly increased in the LT
group compared with the BA group and decreased in the BA
group compared with the normal control group (Figure 3,
Table 2).
TheMDA level decreased in the LT group compared with
the BA and hepatitis groups (Figure 4).
3.3. Correlations between the Severity of Cholestasis and
Oxidative Stress and Antioxidant Enzyme Activity. The sever-
ity of cholestasis is directly related to the oxidative stress level
and inversely related to the antioxidative level [19]. The total
bilirubin level significantly correlated with the levels of MDA





















Figure 4:Themalondialdehyde (MDA) level in plasma decreased in
patients after liver transplantation (LT) comparedwith biliary atresia
(BA) patients before LT and the hepatitis group. Data represent the
mean ± SE. ∗
𝑃
< 0.05 versus BA.
Table 2: Comparison of liver supernatant (randomly selected cases)
between mean levels (±SE) of glutathione peroxidase and catalase
(CAT) enzymes in different cholestasis groups and control children.
Variable GPx (nmol/min/mL) CAT (nmol/min/mL)
Normal (𝑛 = 3) 67.01 ± 6.32∗ 10.57 ± 2.37∗
BA (𝑛 = 10) 50.05 ± 4.26 7.11 ± 1.53
LT (𝑛 = 10) 72.48 ± 5.21∗ 12.00 ± 1.34∗
Hepatitis (𝑛 = 4) 49.01 ± 3.34 10.26 ± 1.62
BA: biliary atresia before liver transplantation; CAT: catalase; GPx: glu-
tathione peroxidase; LT: biliary atresia after liver transplantation; ∗𝑃 < 0.05
versus BA.
and GSH (𝑟 = −0.478, 𝑃 = 0.001). The total bilirubin level
significantly correlated with the levels of AST (𝑟 = 0.612,
𝑃 < 0.001) and ALT (𝑟 = 0.467, 𝑃 = 0.001). However,
the correlation between total bilirubin and CAT levels (𝑟 =
−0.022, 𝑃 = 0.887) and mtDNA copy number (𝑟 = 0.006,
𝑃 = 0.971) was not significant.



































Figure 5: Comparison of the mitochondrial DNA (mtDNA) copy
number in plasma between patients with biliary atresia (BA) and
those receiving liver transplantation (LT), using the relative copy
number (Rc) = 2ΔCt, where ΔCt is Ct
𝛽-𝑎𝑐𝑡𝑖𝑛− CtmtDNA. The mtDNA
copy number increased in the LT group compared with the BA
group. Data represent the mean ± SE. ∗
𝑃
< 0.05 versus BA.
3.4. Post-LT mtDNA Copy Numbers. ThemtDNA copy num-
bers were compared between the BA and LT groups by
calculating the relative copy number (Rc) = 2ΔCt, where ΔCt
is Ct
𝛽-𝑎𝑐𝑡𝑖𝑛−CtmtDNA.ThemtDNA copy numbers increased in
the LT group compared with the BA group (Figure 5).
4. Discussion
This studymore clearly indicates that both the mitochondrial
number and the level of oxidative stress are involved in BA
and that both the number of mitochondria and their antiox-
idant enzymes or their activity recover after LT. Therefore,
the manipulation of mitochondria-associated antioxidative
activity may be important in the management of BA even
after LT. A thorough understanding of the mitochondrial
influence on disease occurrence and progression is therefore
crucial for the treatment of BA patients.
BA-induced obstructive jaundice in children is an impor-
tant clinical issue [1, 20, 21] that is associated with high
morbidity and mortality rates [1]. Bile flow impairment
leads to progressive liver injury, fibrosis, and end-stage liver
cirrhosis. If not treated properly and effectively, LT is required
for survival in most cases [1].The pathogenesis of this disease
is largely undefined, and there are no effective strategies to
prevent its development. Studies exploring the underlying
mechanisms, in particular those investigating protein pro-
files, have been limited by the inability to investigate the
biliary tree at the onset of disease and to trace the progression
of bile duct obstruction at defined phases. Many studies
have reported increased antioxidant enzyme levels in BA and
other liver diseases [9, 22, 23], although some demonstrated
a decrease in antioxidant enzyme levels [7, 8]. In this study,
we evaluated the levels of several antioxidant enzymes and
oxidative stress markers at different stages, with emphasis
on the BA and post-LT conditions, and gained a clearer
understanding of BA pathogenesis that is relevant to its
management strategy.
Oxidative stress is a major pathogenic event that occurs
in several liver disorders, ranging from metabolic to pro-
liferative conditions, and is a major cause of liver damage
during LT [24]. Numerous studies have shown that oxidative
stress is involved in the pathogenesis of cholestasis [25]
and lipid peroxidation is responsible for the tissue injury
that occurs in this condition [26]. End-stage liver cirrhosis
accounts for approximately one-third of patients referred
for LT [25]. Several enzymatic (i.e., CAT and GPx) and
nonenzymatic (i.e., GSH andMDA levels)markers of chronic
oxidative stress in the liver are well known [24]. Patients
with jaundice have significantly higher mean levels of plasma
lipid peroxides such as MDA and bilirubin than patients
without jaundice [27]. Impairment of bile flow is likely to
result in the accumulation of toxic hydrophobic bile salts








22, 28]. Identification of these markers will enable the early
detection of liver diseases and will allow for monitoring
the degree of liver damage, response to pharmacological
therapies, and development of new therapeutic approaches
[24, 29]. Many studies in humans and in rat models have
been conducted to clarify the relationship between oxidative
stress and antioxidants in the liver. In humans, an increase
in the production of free oxygen radicals activates a com-
plex defense system. This system includes GPx, CAT, GSH,
glutathione reductase, and vitamins [26]. Our study showed
a significant decrease in GSH, GPx, and CAT activities in
patients with BA compared with their activities in the control
group, which recovered after LT. In line with Salem et al.’s
study [7], the levels of CAT in hepatitis or liver cirrhosis
were low and presumably related to the effects of oxidative
stress [8]. A marked decrease in the antioxidant status may
lead to excess oxygen free radical formation, which promotes
pathological processes in the liver.
In Granot et al.’s study [29], the levels of oxidants and
antioxidants did not differ between cyclosporine A- (CsA-)
treated patients after LT and healthy controls. In our study,
markedly higher oxidative stress levels were related to more
severe cholestasis. CsA binds to lipoproteins, primarily low-
density lipoprotein phospholipids, which are expected to be
particularly susceptible to lipid peroxidation [29]. In this
study, we determine whether the high antioxidative enzyme
levels were induced by LT or by CsA.More research is needed
to clarify this issue.The administration of suitable antioxidant
therapy just before the reestablishment of blood flow to the
graft is important to prevent plasma redox imbalance and to
prevent or ameliorate post-LT cholestatic injury of the liver
graft [30].
Mitochondria are the major supplier of energy in mam-
malian cells [31] and provide energy necessary for the damage
repair and cellular survival in response to the exposure of the
environment during disease processes such as oxidative stress
[31]. To meet this energy demand, signals are transmitted
to the nucleus for inducing mitochondrial proliferation and
mtDNA amplification for the production of a high number
of functional mitochondria. In this study, the effect of
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mitochondria-associated oxidative stress on the development
of BA that recovered after LT was observed by examining
the plasma redox state and the mtDNA mass. On the basis
of our previous studies, oxidative stress and mitochondrial
intrinsic apoptosis pathways are involved in liver cell death in
the bile duct ligation-induced cholestatic rat model [20, 32,
33]. Early-stage BA is associated with augmented oxidative
DNA, mtDNA damage, and a decrease in mitochondrial
copy number relative to that observed in late-stage BA. Our
study was in accordance with Asakawa’s which described
that postoperative patients with BA were under increased
oxidative stress [17]. Our report also proved that the oxidative
stress increased more in BA before Kasai operation than
after the operation and both are higher than the normal
control [2]. Antioxidant therapy might be necessary to
decrease oxidative stress in postoperative patients with BA
[17]. Thus, altered mitochondrial function and increase in
mitochondrial numbers after LT, in BA pathogenesis, will
provide detailed information about the effects of oxidative
stress on the development of BA, which improves after LT.
These findings also suggest that mitochondrial and oxidative
stress variations could serve as useful biomarkers for early BA
treatment in the future.
In conclusion, the current study demonstrates that GPx,
CAT, and GSH levels are low in patients with BA cholestasis.
The significant increase in their levels after LT may point
to their role as key enzymes in the protection of the liver
from the hazards of free radical reactions and may reflect
the appropriate activity of antioxidant barrier enzymes as a
response to increased oxidative stress. Increased knowledge
of redox regulationmay have important clinical ramifications
for understanding the pathogenesis of BA liver diseases and













ROS: Reactive oxygen species.
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[28] S. Krähenbühl, S. Fischer, C. Talos, and J. Reichen, “Ursodeoxy-
cholate protects oxidative mitochondrial metabolism from bile
acid toxicity: dose-response study in isolated rat livermitochon-
dria,” Hepatology, vol. 20, no. 6, pp. 1595–1601, 1994.
[29] E. Granot, H. Elinav, and R. Kohen, “Markers of oxidative stress
in cyclosporine-treated and tacrolimus-treated children after
liver transplantation,” Liver Transplantation, vol. 8, no. 5, pp.
469–475, 2002.
[30] E. Serrano, J. Dı́az, F. Acosta, P. Parrilla, and L. F. Carbonell,
“Plasma redox imbalance during reperfusion and early post-
transplantation cholestasis parameters in human liver trans-
plantation,”Transplantation Proceedings, vol. 31, no. 6, pp. 2378–
2379, 1999.
[31] H. C. Lee and Y. H. Wei, “Mitochondrial biogenesis and
mitochondrial DNA maintenance of mammalian cells under
oxidative stress,” International Journal of Biochemistry and Cell
Biology, vol. 37, no. 4, pp. 822–834, 2005.
[32] C. H. Ahn, E. G. Jeong, J. W. Lee et al., “Expression of beclin-1,
an autophagy-related protein, in gastric and colorectal cancers,”
APMIS, vol. 115, no. 12, pp. 1344–1349, 2007.
[33] M. M. Tiao, T. K. Lin, C. W. Liou et al., “Early transcriptional
deregulation of hepatic mitochondrial biogenesis and its conse-
quent effects on murine cholestatic liver injury,” Apoptosis, vol.
14, no. 7, pp. 890–899, 2009.



















































 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
